Biolegend, 430104, ELISA MAX™ Deluxe Set Human IFN-γ, 5plates

ELISA Development Systems Engineered for Sensitive, Precise and Reliable Serum and Plasma Cytokine Quantitation BioLegend's ELISA Max™ Sets provide all the time-savings, convenience and performance of a high-end, commercial ELISA kit for a fraction of the price! BioLegend's ELISA Max™ Sets, in two appealing formats, address the need for sensitivity, accuracy, dependability, and versatility of an ELISA development system, while providing maximum cost effectiveness, value, and ease of use. Both the ELISA Max™ Set Standard and ELISA Max™ Set Deluxe are specifically engineered for accurate recovery and measurement of analytes in complex fluids, such as serum and plasma (as well as activated cell cultures) without any interference by confounding serum factors, such as heterophilic antibody or rheumatoid factor.
5plates
Verified Reactivity: Human
Application: ELISA
Application Notes: The assay kits will no longer include ELISA microwell plates. Recommended microwell plates can be purchased separately under Cat. No. 423501. Please contact your BioLegend sales representative for bulk pricing quotations.
Application References(PubMed link indicates BioLegend citation): Ye Z, et al. 2008. Infect Immun. 75:2541. PubMed Zhang Y, et al. 2010. Infect Immun. 78:2329. PubMed Peng J, et al. 2005. J. Immunother. 28:599. PubMed Bendersky A, et al. 2012. J. Immunol. 188:4349. PubMed Boggio E, et al. 2012. Hum Immunol. 73:585. PubMed Ankrum JA, et al. 2014. Sci Rep. 4:4645. PubMed Wu Z, et al. 2015. J Virol. 89:2906. PubMed
Product Citations: Wu Z, et al. 2015. J Virol. 89:2906. PubMed Klement JD, et al. 2018. J Clin Invest. 128:5549. PubMed McKenzie C, et al. 2023. Mol Ther Nucleic Acids. 32:603. PubMed Leland P, et al. 2023. J Transl Med. 21:367. PubMed Loh HP, et al. 2023. MAbs. 2231129:15. PubMed Cordoba S, et al. 2021. Nat Med. 27:1797. PubMed Heitzeneder S, et al. 2022. Cancer Cell. 40:53. PubMed Shemesh A, et al. 2022. J Exp Med. 219: . PubMed Bigenwald C, et al. 2023. Oncoimmunology. 12:2163785. PubMed Sheng YR, et al. 2022. Cell Mol Life Sci. 79:173. PubMed Labanieh L, et al. 2022. Cell. 185:1745. PubMed Scurr MJ, et al. 2022. Nat Commun. 13:5422. PubMed Bröker K, et al. 2019. J Transl Med. 17:6. PubMed Kilcollins A, et al. 2016. J Immunol. 197: 419 - 428. PubMed Meryk A et al. 2019. Cell reports. 26(10):2681-2691 . PubMed Pires D, et al. 2021. Front Immunol. 12:742822. PubMed Singh N, et al. 2018. PLoS One. 13:e0199817. PubMed Singhal J, et al. 2022. Front Cell Infect Microbiol. 12:878136. PubMed Wang H, et al. 2021. J Immunother Cancer. 9:. PubMed Boggio E, et al. 2012. Hum Immunol. 73:585. PubMed Bendersky A, et al. 2012. J Immunol. 188:4349. PubMed Ye Z, et al. 2008. Infect Immun. 76:2541. PubMed Ollé Hurtado M, et al. 2019. PLoS One. 14:e0216373. PubMed Booty MG, et al. 2022. J Immunol. 208:929. PubMed Ankrum J, et al. 2014. Sci Rep. 4:4645. PubMed You Y, et al. 2021. Mol Med Rep. 24:. PubMed Karampetsou M, et al. 2016. J Immunol. 196: 4915 - 4924. PubMed Aldeghaither DS, et al. 2019. Cancer Immunol Res. 7:230. PubMed Kofla G, et al. 2022. Oncoimmunology. 11:2068109. PubMed Godbersen C, et al. 2017. Mol Cancer Ther. 16:1335. PubMed Sp N, et al. 2021. Int J Mol Sci. 22:. PubMed Hirschberger S, et al. 2022. Front Med (Lausanne). 9:923502. PubMed Liu CA, et al. 2022. Cancers (Basel). 14:. PubMed Madison BB, et al. 2022. Mol Ther Nucleic Acids. 29:979. PubMed Fernandes RA, et al. 2020. Nature. 779:586. PubMed Bliska Y 2010. Infect Immun. 78:2359. PubMed Leung EYL, et al. 2020. Mol Ther Oncolytics. 16:289. PubMed Wu Z, et al. 2019. Microorganisms. 0.670833333. PubMed Trinklein ND, et al. 2019. MAbs. 11:639. PubMed Feng Y, et al. 2022. Life (Basel). 12:. PubMed Xie X, et al. 2021. Front Immunol. 12:625808. PubMed Hirschberger S, et al. 2021. EMBO Mol Med. 13:e14323. PubMed Subramanian N, et al. 2017. J Gen Virol. 98(12). PubMed Pires D, et al. 2021. Front Immunol. 12:647728. PubMed Kang CH, et al. 2020. Int J Mol Sci. 21:00. PubMed Zhang X, et al. 2019. Hematol Oncol. 37(3):270. PubMed Iraqi M, et al. 2022. Int J Mol Sci. 23:. PubMed Pierini S, et al. 2020. JCI Insight. 5:00. PubMed Dammermann W, et al. 2017. J Virol Methods. 10.1016/j.jviromet.2017.07.011. PubMed Singh SS, et al. 2022. Clin Transl Immunology. 11:e1396. PubMed Wang E, et al. 2015. Cancer Immunol Res. 3: 815 - 826. PubMed Kunyanee C, et al. 2016. PLoS One. 11: 0160741. PubMed Lei W, et al. 2022. Blood Cancer J. 12:35. PubMed Lucchesi D, et al. 2020. Arthritis Rheumatol. 1559:72. PubMed Singh N, et al. 2017. Mol Immunol. 85:111. PubMed
Sensitivity: 4 pg/mL
Standard Range: 7.8-500 pg/mL
Cell Sources: CD8+ and CD4+ T cells, NK cells
Cell Type: Tregs
Biology Area: Immunology, Innate Immunity, Neuroinflammation, Neuroscience
Molecular Family: Cytokines/Chemokines
Gene ID: 3458
UniProt: View information about IFN-gamma on UniProt.org
Regulatory Status: RUO
Other Names: IFN-g ELISA Kit
Q: Do the ELISA MAX™ Deluxe Sets come with plates?
A: No, ELISA MAX™ Deluxe Sets do not come with plates. Coating Buffer and Assay Diluent (for blocking and dilutions) are included in these sets. Plates can be ordered separately (Cat No. 423501), and instructions for coating the plates are in the sets’ product manuals.